Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 203.79 |
| Open | 208.14 |
| Bid | 203.98 x 800 |
| Ask | 221.41 x 900 |
| Day's range | 207.31 - 213.44 |
| 52-week range | 181.36 - 449.34 |
| Volume | |
| Avg. volume | 576,803 |
| Market cap | 10.469B |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | 23.89 |
| EPS (TTM) | 8.92 |
| Earnings date | 01 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 273.50 |
- Zacks
Charles River (CRL) Gains From Growing Demand Amid Macro Woes
Charles River (CRL) continues to expect that the growth rate will approach 20% in the second half of 2022.
- Zacks
Charles River (CRL) to Support Cure AP-4's Clinical Trials
Charles River's (CRL) manufacturing collaboration with Cure AP-4 will support the latter's Phase I/II gene therapy trials for a rare neurodegenerative disorder.
- Business Wire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
WILMINGTON, Mass., September 08, 2022--Charles River Laboratories to Present at September Conferences
© 2022 Yahoo. All rights reserved.
